Background Characteristics and Clinical Data of Study Population According to Acute Pancreatitis with Identified versus Unknown Etiology.
Background Characteristics and Clinical Data of Study Population According to Acute Pancreatitis with Identified versus Unknown Etiology.
| Variable | Total (n=560) | Identified Etiology (n=359) | Idiopathic (n=201) | P Value |
|---|---|---|---|---|
| Demographics | ||||
| Males, n (%) | 259 (46.3) | 153 (42.6) | 106 (52.7) | 0.022 |
| Age, years, mean±SD | 61.9 (19.1) | 62.5 (18.9) | 61.0 (19.5) | 0.376 |
| Jewish, n (%) | 483 (86.3) | 307 (85.5) | 176 (87.6) | 0.525 |
| Israel born, n (%) | 217 (38.8) | 133 (37.0) | 84 (41.8) | 0.279 |
| Background Diseases | ||||
| Chronic ischemic heart disease, n (%) | 37 (6.6) | 26 (7.2) | 11 (5.5) | 0.481 |
| Dyslipidemia, n (%) | 180 (32.1) | 121 (35.1) | 59 (32.4) | 0.563 |
| Chronic obstructive pulmonary disease, n (%) | 41 (7.3) | 29 (8.1) | 12 (6.0) | 0.402 |
| Diabetes, n (%) | 159 (28.4) | 92 (25.6) | 67 (33.3) | 0.063 |
| Chronic kidney disease, n (%) | 72 (12.9) | 45 (12.5) | 27 (13.4) | 0.793 |
| Liver disease, n (%) | 124 (22.1) | 88 (25.5) | 36 (19.8) | 0.161 |
| Malignancy, n (%) | 34 (6.1) | 26 (7.5) | 8 (4.4) | 0.194 |
| Charlson co-morbidity index >1, n (%) | 99 (17.7) | 61 (17.0) | 38 (18.9) | 0.566 |
| Previous admission with pancreatitis, n (%) | 123 (22.0) | 83 (23.1) | 40 (19.9) | 0.397 |
| Chronic Medications | ||||
| ACE/ARBs, n (%) | 247 (44.1) | 149 (56.0) | 98 (68.1) | 0.020 |
| Diuretics, n (%) | 88 (15.7) | 58 (21.8) | 30 (20.8) | 0.900 |
| Anti-diabetic drug, n (%) | 93 (16.6) | 46 (17.3) | 47 (32.6) | 0.001 |
| Lipid-lowering drug, n (%) | 258 (46.1) | 157 (59.0) | 101 (70.1) | 0.032 |
| Vital signs on admission | ||||
| O2 saturation <90%, n (%) | 7 (1.3) | 1 (0.3) | 6 (3.0) | 0.006 |
| Modified Glasgow Score | ||||
| Albumin <3.2 g/dL, n (%) | 83 (14.8) | 65 (18.1) | 18 (9.0) | 0.004 |
| Calcium <8.0 mg/dL, n (%) | 34 (6.1) | 27 (7.5) | 7 (3.5) | 0.065 |
| Glucose >180 mg/dL, n (%) | 66 (11.8) | 41 (11.4) | 25 (12.4) | 0.785 |
| LDH >600 U/L, n (%) | 74 (13.2) | 54 (15.00) | 20 (10.0) | 0.092 |
| Urea >45 mg/dL, n (%) | 125 (22.3) | 82 (22.8) | 43 (21.4) | 0.751 |
| WBC >15.0×103/μL, n (%) | 74 (13.2) | 51 (14.2) | 23 (11.4) | 0.435 |
| ALT >150 U/L, n (%) | 174 (31.1) | 135 (37.6%) | 39 (19.4) | <0.001 |
| Modified Glasgow score >2, n (%) | 103 (18.4) | 71 (19.8) | 32 (15.9) | 0.306 |
| Lipase, U/L, mean±SD | 737±1129 | 850±1186 | 615±1012 | 0.061 |
| Amylase, U/L, mean±SD | 451±534 | 498±561 | 367±469 | 0.004 |